These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5624129)

  • 41. Inhibition of liver aldehyde dehydrogenase by pyrogallol and related compounds.
    Rubenstein JA; Collins MA; Tabakoff B
    Experientia; 1975 Apr; 31(4):414-5. PubMed ID: 1120498
    [No Abstract]   [Full Text] [Related]  

  • 42. Inhibition of the COMT activity by 1-(3,4,5-trimethoxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1-(3,5-dimethoxy-4-hydroxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline in vitro.
    Hattori K; Matsuura M; Shimamoto K
    Jpn J Pharmacol; 1969 Jun; 19(2):287-90. PubMed ID: 5308833
    [No Abstract]   [Full Text] [Related]  

  • 43. 5,6-Dihydroxytryptamine is a substrate for catechol O-methyltransferase.
    Fuller RW; Roush BW
    Biochem Pharmacol; 1974 Aug; 23(15):2208-9. PubMed ID: 4416934
    [No Abstract]   [Full Text] [Related]  

  • 44. Characterization of liver microsomal cytochrome P450 from rats treated with muscone (3-methylcyclopentadecanone).
    Tanaka E; Funae Y; Imaoka S; Misawa S
    Biochem Pharmacol; 1991 Feb; 41(3):472-3. PubMed ID: 1994906
    [No Abstract]   [Full Text] [Related]  

  • 45. Sensitization to the generalized Shwartzman reaction by catechol-O-methyltransferase inhibitors.
    Latour JG; Láger-Gauthier C
    Am J Pathol; 1978 Aug; 92(2):377-87. PubMed ID: 677267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis of bridged catechol-homocysteine derivatives as potential inhibitors of catechol O-methyltransferase.
    Lever OW; Hyman C; White HL
    J Pharm Sci; 1984 Sep; 73(9):1241-4. PubMed ID: 6491941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Catechol-O-methyl transferase and monoamine oxidase activities in the heart and liver of the embryonic and developing chick.
    Ignarro LJ; Shideman FE
    J Pharmacol Exp Ther; 1968 Jan; 159(1):29-37. PubMed ID: 5643948
    [No Abstract]   [Full Text] [Related]  

  • 48. Catechol-O-methyl transferase in erythrocytes and fat cells.
    Horst WD; Gattanell P; Urbano S; Sheppard H
    Life Sci; 1969 May; 8(10):473-6. PubMed ID: 5793504
    [No Abstract]   [Full Text] [Related]  

  • 49. The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.
    Xiao ZP; Ma TW; Fu WC; Peng XC; Zhang AH; Zhu HL
    Eur J Med Chem; 2010 Nov; 45(11):5064-70. PubMed ID: 20801557
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of curcumin on serum and liver cholesterol levels in the rat.
    Rao DS; Sekhara NC; Satyanarayana MN; Srinivasan M
    J Nutr; 1970 Nov; 100(11):1307-15. PubMed ID: 5476433
    [No Abstract]   [Full Text] [Related]  

  • 51. Uptake of normetanephrine and norepinephrine by cocaine-treated rat heart.
    Simmonds MA; Gillis CN
    J Pharmacol Exp Ther; 1968 Feb; 159(2):283-9. PubMed ID: 5638649
    [No Abstract]   [Full Text] [Related]  

  • 52. A new class of tyrosine hydroxylase inhibitors and a simple assay of inhibition in vivo.
    Levitt M; Gibb JW; Daly JW; Lipton M; Udenfriend S
    Biochem Pharmacol; 1967 Jul; 16(7):1313-21. PubMed ID: 6053599
    [No Abstract]   [Full Text] [Related]  

  • 53. Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O-methyltransferase-mediated metabolism of catechol estrogens.
    Garner CE; Burka LT; Etheridge AE; Matthews HB
    Toxicol Appl Pharmacol; 2000 Jan; 162(2):115-23. PubMed ID: 10637135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of catechol glucuronidation in rat liver.
    Antonio L; Grillasca JP; Taskinen J; Elovaara E; Burchell B; Piet MH; Ethell B; Ouzzine M; Fournel-Gigleux S; Magdalou J
    Drug Metab Dispos; 2002 Feb; 30(2):199-207. PubMed ID: 11792691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [INHIBITION OF CATECHOL O-METHYL TRANSFERASE; ITS ROLE IN THE MECHANISMS OF TOXIC ACTION].
    TRUHAUT R; ASSICOT M; BOHUON C
    Ann Biol Clin (Paris); 1964; 22():1047-54. PubMed ID: 14232089
    [No Abstract]   [Full Text] [Related]  

  • 56. Assessment of catechol induction and glucuronidation in rat liver microsomes.
    Elovaara E; Mikkola J; Luukkanen L; Antonio L; Fournel-Gigleux S; Burchell B; Magdalou J; Taskinen J
    Drug Metab Dispos; 2004 Dec; 32(12):1426-33. PubMed ID: 15371300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phenolic Metabolites Modulate Cardiomyocyte Beating in Response to Isoproterenol.
    Dias-Pedroso D; Guerra J; Gomes A; Oudot C; Brenner C; Santos CN; Vieira HLA
    Cardiovasc Toxicol; 2019 Apr; 19(2):156-167. PubMed ID: 30302669
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Consumption of adrenaline and hepatic glycogenolysis before and after monoamine oxidase (MAO) and catechol-O-methyltransferase block].
    FOGLIA VG; DOMINGUEZ AE; RAMASSO JC
    Rev Soc Argent Biol; 1961 Apr; 37():1-8. PubMed ID: 13893773
    [No Abstract]   [Full Text] [Related]  

  • 59. Letter: Evidence for O-methylation of catechol estrogen 2-glucuronoside with retention of conjugate in the rat.
    Honma S; Nambara T
    Chem Pharm Bull (Tokyo); 1974 Aug; 22(8):1952-4. PubMed ID: 4430054
    [No Abstract]   [Full Text] [Related]  

  • 60. Biochemistry and pharmacology of catechol-O-methyltransferase inhibitors.
    Nissinen E; Männistö PT
    Int Rev Neurobiol; 2010; 95():73-118. PubMed ID: 21095460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.